From 2013 to 2023, Greece's per capita market size for contraceptives based on hormones or spermicides decreased significantly from $1.84 to $0.95. Over the last decade, the most notable fluctuations include a steady decline from 2013 until 2018, a slight recovery in 2019 and 2020, followed by another drop reaching the 2023 value. Year-on-year, the decline in the last two years was approximately 5% annually. The CAGR over the past five years shows an average annual reduction of about 5.6%.
Future trends to watch include potential market stabilization or growth influenced by changing societal norms, increased health awareness, and advancements in contraceptive technologies. Monitoring the impacts of government health policies and economic conditions will also be crucial.
